Novartis: Revenue Lags In Q1, Outlook Unchanged
We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-04-28T19:18:18.000Z","dateModified":"2026-04-29T08:07:37.000Z","description":"Novartis missed Q1 revenue and EPS estimates, but key growth products remain strong, and full-year guidance was reaffirmed. Learn More » Jennifer Miranda/iStock via Getty Images Novartis (NVS) reported first-quarter results today, missing revenue and EPS estimates.
- ▪We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools.
- ▪Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-04-28T19:18:18.000Z","dateModified":"2026-04-29T08:07:37.000Z","description":"Novartis missed Q1 revenue and EPS estimates, but key growth produc
- ▪Learn More » Jennifer Miranda/iStock via Getty Images Novartis (NVS) reported first-quarter results today, missing revenue and EPS estimates.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Earnings Analysis","item":"https://seekingalpha.com/earnings/earnings-analysis"},{"@type":"ListItem","position":3,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4895288-novartis-revenue-lags-in-q1-outlook-unchanged"},"author":{"@type":"Person","name":"ONeil…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
